Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, Next
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2023-02-14
3:00 pm
Sale
13GSutro Biopharma, Inc.
STRO
EVENTIDE ASSET MANAGEMENT LLC0
0%
-2,708,975decrease
(Position Closed)
View
2023-02-14
11:45 am
Purchase
13GSutro Biopharma, Inc.
STRO
BIOTECHNOLOGY VALUE FUND L P3,347,946
5.8%
187,530increase
(+5.93%)
View
2023-02-13
10:56 am
Purchase
13GSutro Biopharma, Inc.
STRO
SUVRETTA CAPITAL MANAGEMENT LLC5,565,099
9.7%
3,091,304increase
(+124.96%)
View
2023-02-10
4:00 pm
Purchase
13GSutro Biopharma, Inc.
STRO
Rubric Capital Management LP3,211,872
5.59%
3,211,872increase
(New Position)
View
2023-02-07
2:55 pm
Purchase
13GSutro Biopharma, Inc.
STRO
BlackRock Inc.
BLK
4,860,140
8.5%
1,160,097increase
(+31.35%)
View
2023-02-01
1:09 pm
Sale
13GSutro Biopharma, Inc.
STRO
FRANKLIN RESOURCES INC
BEN
2,838,135
4.9%
-429,812decrease
(-13.15%)
View
2023-01-23
4:31 pm
Sale
13GSutro Biopharma, Inc.
STRO
MILLENNIUM MANAGEMENT LLC1,369,021
2.4%
-1,053,652decrease
(-43.49%)
View
2022-07-08
4:19 pm
Purchase
13GSutro Biopharma, Inc.
STRO
MILLENNIUM MANAGEMENT LLC2,422,673
5.2%
2,422,673increase
(New Position)
View
2022-02-14
12:00 pm
Purchase
13GSutro Biopharma, Inc.
STRO
EVENTIDE ASSET MANAGEMENT LLC2,708,975
5.9%
338,000increase
(+14.26%)
View
2022-02-11
4:49 pm
Purchase
13GSutro Biopharma, Inc.
STRO
SUVRETTA CAPITAL MANAGEMENT LLC2,473,795
5.4%
65,400increase
(+2.72%)
View
2022-02-04
1:45 pm
Purchase
13GSutro Biopharma, Inc.
STRO
FRANKLIN RESOURCES INC
BEN
3,267,947
7.1%
3,267,947increase
(New Position)
View
2022-02-02
7:18 pm
Purchase
13GSutro Biopharma, Inc.
STRO
BlackRock Inc.
BLK
3,700,043
8%
982,114increase
(+36.13%)
View
2022-01-18
5:18 pm
Purchase
13GSutro Biopharma, Inc.
STRO
BIOTECHNOLOGY VALUE FUND L P3,160,416
6.8%
1,306,254increase
(+70.45%)
View
2021-12-10
4:31 pm
Purchase
13GSutro Biopharma, Inc.
STRO
SUVRETTA CAPITAL MANAGEMENT LLC2,408,395
5.2%
2,408,395increase
(New Position)
View
2021-04-05
5:28 pm
Purchase
13GSutro Biopharma, Inc.
STRO
BRISTOL MYERS SQUIBB CO
BMY
1,726,197
3.8%
1,726,197increase
(New Position)
View
2021-02-16
4:30 pm
Sale
13GSutro Biopharma, Inc.
STRO
CITADEL ADVISORS LLC1,301,804
2.9%
-427,172decrease
(-24.71%)
View
2021-02-16
4:22 pm
Sale
13GSutro Biopharma, Inc.
STRO
Ridgeback Capital Investments L.P.1,144,979
2.5%
-869,708decrease
(-43.17%)
View
2021-02-16
08:57 am
Sale
13GSutro Biopharma, Inc.
STRO
Alta Partners VIII L.P.0
0%
-1,948,516decrease
(Position Closed)
View
2021-02-12
5:23 pm
Sale
13GSutro Biopharma, Inc.
STRO
EcoR1 Capital LLC93,416
0.2%
-2,235,076decrease
(-95.99%)
View
2021-02-12
4:25 pm
Sale
13GSutro Biopharma, Inc.
STRO
BIOTECHNOLOGY VALUE FUND L P1,854,162
4.1%
-514,230decrease
(-21.71%)
View
Goto 0, 1, Next